arGEN-X N.V.

About arGEN-X N.V.

arGEN-X is a global immunology company focused on developing a pipeline of antibody-based therapies for patients suffering from severe autoimmune diseases and cancer. The company leverages its powerful FcRn antagonist technology and broad pipeline to address a range of debilitating conditions. arGEN-X is committed to transforming the standard of care for these diseases and improving patient outcomes. Their approach involves deep scientific understanding of immunology and a dedication to innovation, aiming to deliver breakthrough treatments to those in need. They are driven by a mission to make a meaningful difference in the lives of patients worldwide.